切换至 "中华医学电子期刊资源库"

中华关节外科杂志(电子版) ›› 2021, Vol. 15 ›› Issue (06) : 660 -665. doi: 10.3877/cma.j.issn.1674-134X.2021.06.002

临床论著

髋关节表面置换术后金属离子水平随访研究
万彦林1, 尤佳1, 姜文学1,(), 范猛1, 王鹏飞1   
  1. 1. 300192 天津市第一中心医院
  • 收稿日期:2020-05-30 出版日期:2021-12-01
  • 通信作者: 姜文学

Study of metal ion levels after hip resurfacing arthroplasty

Yanlin Wan1, Jia You1, Wenxue Jiang1,(), Meng Fan1, Pengfei Wang1   

  1. 1. Tianjin First Central Hospital, Tianjin 300192, China
  • Received:2020-05-30 Published:2021-12-01
  • Corresponding author: Wenxue Jiang
引用本文:

万彦林, 尤佳, 姜文学, 范猛, 王鹏飞. 髋关节表面置换术后金属离子水平随访研究[J/OL]. 中华关节外科杂志(电子版), 2021, 15(06): 660-665.

Yanlin Wan, Jia You, Wenxue Jiang, Meng Fan, Pengfei Wang. Study of metal ion levels after hip resurfacing arthroplasty[J/OL]. Chinese Journal of Joint Surgery(Electronic Edition), 2021, 15(06): 660-665.

目的

探讨金对金髋关节表面置换术(HRA)后金属离子水平的变化趋势。

方法

回顾性分析2006年9月至2016年8月接受金对金HRA并有完整随访资料的患者72例81髋,男30例31髋,女42例50髋;年龄24~66岁。术前诊断髋臼发育不良29髋(35.8%);股骨头坏死34髋(42.0%);骨关节炎3髋(3.7%);类风湿关节炎5髋(6.2%);强直性脊柱炎10髋(12.3%),排除金属离子过敏、使用含金属药物等患者。采用美国Wright公司Conserve Plus假体22髋,英国Smith & Nephew公司的伯明翰表面髋置换系统(BHR或BMHR)假体59髋。术前随机选取20例患者检测血清金属离子水平,作为对照组。使用电感耦合等离子体质谱仪检测术前及术后3、6个月以及术后每年血清样本中钴(Co)、铬(Cr)、钼(Mo)离子水平,使用t检验比较术前术后金属离子水平差异,同时间点Co、Cr、Mo离子水平采用单因素重复测量资料的方差分析。

结果

平均随访(7.9 ± 0.3)年,Co、Cr、Mo三种离子术前水平分别为(1.13±0.24)μg/L、(2.22±0.54)μg/L、(2.62±1.00)μg/L。术后三种金属离子水平均升高,其中Co离子和Cr离子与术前比较差异有统计学意义(F=51.93、61.00,均为P<0.05)。Co离子在术后6个月达到高峰,为术前3.2倍,然后开始逐渐下降,至术后7年基本恢复到术前水平,术后8年及10年Co离子水平再次升高,分别为术前2.0倍和2.5倍,差异有统计学意义(均为P<0.05),此后Co离子水平逐渐下降,术后13年,Co离子基本恢复术前水平,为(1.28± 0.79)μg/L。术后1年,Cr离子水平达到高峰,是术前2.2倍,较术前差异有统计学意义(P<0.05),术后7年,Cr离子升高到与顶峰时离子水平相似,是术前水平2.0倍,差异有统计学意义(P<0.05)。此后Cr离子水平始终处于下降趋势,至术后13年,Cr离子水平低于术前,差异没有统计学意义(P>0.05)。Mo离子水平术后升高,但与术前相比差异没有统计学意义(F=35.93,P>0.05);Mo离子术后3个月达到随访期的高峰,是术前的2.23倍;术后4年,Mo离子水平出现明显下降过程,术后8年Mo离子水平最低,为(2.62±1.43)μg/L,较术前差异没有统计学意义(P>0.05),术后9年至10年,离子水平再次升高,为(5.29±2.07)μg/L,是术前2.0倍,术后13年下降至术前水平(P>0.05)。

结论

金对金HRA术后早期金属离子水平均升高并达到高峰,中长期金属离子水平存在波动,但总体呈下降趋势。对于金属离子水平的变化情况需继续密切监测及观察。

Objective

To investigate the mid-and long-term trend of metal ion levels after metal-on-metal hip resurfacing arthroplasty.

Methods

A retrospective analysis was performed on 72 patients with 81 hips, including 30 males (31 hips)and 42 females(50 hips)who underwent metal-on-metal hip resurfacing arthroplasty in Tianjin First Central Hospital from September 2006 to August 2016. The age range was 24-66 years. Twenty-nine hips(35.8%)were diagnosed as acetabular dysplasia before the operation, 34 hips (42.0%) were diagnosed femoral head necrosis, three hips were diagnosed osteoarthritis (3.7%), five hips were diagnosed rheumatoid arthritis (6.2%), 10 hips were diagnosed ankylosing spondylitis (12.3%). The patients who were allergic to metal ions and using metal-containing drugs were excluded. Twenty-two hips used Conserve Plus prosthesis from Wright Company(USA), and 59 hips used Birmingham Hip Resurfacing or Birmingham Mid Head Resection System (BHR or BMHR) from Smith & Nephew Company (United Kingdom). Serum samples from 20 patients were randomly selected before surgery to detect metal ion levels, and served as control groups. Inductively coupled plasma mass spectrometer was used to detect the levels of Co, Cr and Mo ions in serum samples before and after surgery, three months, six months, and every year after surgery, and analyze their changes. The t-test was used to compare the differences in metal ion levels before and after surgery, and the Co, Cr, and Mo ion levels at the same time point were analyzed by single-factor repeated measurement data analysis of variance.

Results

The mean follow-up time was (7.85±0.34)years. The preoperative levels of Co, Cr and Mo were (1.13±0.24)μg/L, (2.22±0.54)μg/L, and(2.62±1.00)μg/L. The levels of the three metal ions increased after the operation, among which the differences of Co and Cr ion levels were statistically significant (F=51.93, 61.00, both P<0.05). Co ions reached a peak six months after the operation, 3.2 times to that before the operation, and then gradually decreased. Seven years after the operation, the levels of Co ions returned to the levels before the operation. The levels of metal ions increased again at eight years and 10 years after surgery, 2.0 times and 2.5 times to that before surgery respectively, and the differences were statistically significant (both P<0.05). After 10 years, the levels of metal ions gradually decreased to 13 years after surgery. Co ion level basically recovered to the preoperative level, (1.28±0.79)μg/L. One years after Cr ion, the metal ion level reached a peak, which was 2.2 times to that before the operation, and the difference was statistically significant (P<0.05) At seven years after operation, the metal ion level increased significantly, compared with the metal ion level at the peak. Similarly, it was 2.0 times to the metal ion level before surgery, and the difference was statistically significant (P<0.05). The level of metal ions was in a downward trend. By 13 years after operation, the level of metal ions was lower than before surgery, and the difference was not statistically significant (P>0.05). Although Mo ion level increased following the surgery, the difference was not statistically significant(F=35.93, P>0.05). Mo ion level reached the peak of the follow-up period at three months after the operation, which was 2.2 times to the preoperative level. Four years after the operation, Mo ion level showed a significant decline process, and Mo ion was the lowest eight years after the operation. The lowest level was (2.62±1.43) μg/L, which was not statistically significant compared with preoperative difference (P>0.05). From nine to 10 years after operation, the ion level increased again, which was (5.29±2.07) μg/L, which was 2.02 times preoperatively, and reached a plateau, dropped to the preoperative level 13 years after operation, yet the difference was not statistically significant (P>0.05).

Conclusions

After metal-on-metal hip resurfacing arthroplasty, in the early stage increased and reached a peak, and the metal ion level in the medium and long term shows a downward trend. The fluctuation of metal ion level needs to be continuously monitored and closely observed.

图1 HRA(髋关节表面置换术)术后血清中金属离子水平变化
表1 不同随访时间三种金属离子水平[μg/L,(± s)]
[1]
Daniel J, Pynsent PB, Mcminn DJ. Metal-on-metal resurfacing of the hip in patients under the age of 55 years with osteoarthritis[J]. J Bone Joint Surg Br, 2004, 86(2): 177-184.
[2]
沈彬,黄强,杨静,等.全髋关节表面置换术治疗髋关节发育不良继发骨关节炎的早期疗效观察[J].中华骨科杂志201030(4):357-362.
[3]
姜文学,尤佳,李轶津,等.髋关节表面置换术的近期疗效及其并发症分析[J].中华骨科杂志200929(9):858-863.
[4]
Amstutz HC, Beaulé PE, Dorey FJ, et al. Metal-on-metal hybrid surface arthroplasty: two to six-year follow-up study[J]. J Bone Joint Surg Am, 2004, 86-A (1): 28-39.
[5]
姜文学,周思佳,尤佳,等.金对金髋关节表面置换术的中长期疗效[J].中华骨科杂志201838(17):1025-1035.
[6]
Mcminn DJ, Daniel J, Ziaee H, et al. Indications and results of hip resurfacing[J]. Int Orthop, 2011, 35(2): 231-237.
[7]
Kim PR, Beaulé PE, Dunbar M, et al. Cobalt and chromium levels in blood and urine following hip resurfacing arthroplasty with the conserve plus implant[J]. J Bone Joint Surg Am, 2011, 93 Suppl 2(2): 107-117.
[8]
Amstutz HC, Campbell PA, Dorey FJ, et al. Do ion concentrations after metal-on-metal hip resurfacing increase over time? A prospective study[J]. J Arthroplasty, 2013, 28(4): 695-700.
[9]
Yang J, Shen B, Zhou Z, et al. Changes in cobalt and chromium levels after metal-on-metal hip resurfacing in young, active Chinese patients[J]. J Arthroplasty, 2011, 26(1): 65-70, 70.e1.
[10]
万彦林,姜文学.髋关节表面置换术后5年血清金属离子水平的变化[J].中国矫形外科杂志201422(3):215-220.
[11]
Cadossi M, Tedesco G, Sambri A, et al. Hip resurfacing implants[J]. Orthopedics, 2015, 38(8): 504-509.
[12]
Hartmann A, Lützner J, Kirschner S, et al. Do survival rate and serum ion concentrations 10 years after metal-on-metal hip resurfacing provide evidence for continued use?[J]. Clin Orthop Relat Res, 2012, 470(11): 3118-3126.
[13]
Savarino L, Cadossi M, Chiarello E, et al. How do metal ion levels change over time in hip resurfacing patients? A cohort study[J/OL]. Sci World J, 2014:291925. DOI: 10.1155/2014/291925.
[14]
Desouza RM, Parsons NR, Oni T, et al. Metal ion levels follow-ing resurfacing arthroplasty of the hip:serial results over a ten-year period[J]. J Bone Joint Surg Br, 2010, 92(12): 1642-1647.
[15]
Daniel J, Ziaee H, Pradhan C, et al. Six-year results of a prospectivestudy of metal ion levels in young patients with metal-on-metal hip resurfacings[J]. J Bone Joint Surg Br, 2009, 91(2): 176-179.
[16]
Jiang W, Wan Y, Cui P, et al. Intermediate-term trends in serum levels of metal ions after hip resurfacing arthroplasty[J/OL]. J Orthop Surg Res, 2015, 10:188. DOI: 10.1186/s13018-015-0335-0.
[17]
Grammatopoulos G, Pandit H, Kwon YM, et al. Hip resurfacings revised for inflammatory pseudotumour have a poor outcome[J]. J Bone Joint Surg Br, 2009, 91(8): 1019-1024.
[18]
Van Der Straeten C, Grammatopoulos G, Gill HS, et al. The 2012 Otto aufranc award:theinterpretation of metal ion levels in unilateral and bilateral hipresurfacing[J]. Clin Orthop Relat Res, 2013, 471(2): 377-385.
[19]
Bisschop R, Boomsma MF, Van Raay JJ, et al. High prevalence of pseudotumors in patients 338 hip resurfacingwith a Birmingham hip resurfacing prosthesis:a prospectivecohort study of one hundred and twenty-nine patients[J]. J Bone Joint Surg Am, 2013, 95(17): 1554-1560.
[20]
Bosker BH, Ettema HB, Boomsma MF, et al. High incidence of pseudotumour formation after large-diameter metal-on-metal total hip replacement: a prospective cohort study[J]. J Bone Joint Surg Br, 2012, 94(6): 755-761.
[21]
Gross TP, Liu F. Incidence of adverse wear reactions in hip resurfacing arthroplasty: a single surgeon series of 2,600 cases[J]. Hip Int, 2013, 23(3): 250-258.
[22]
Kwon YM, Ostlere SJ, Mclardy-Smith P, et al. "Asymptomatic" pseudotumors after metal-on-metal hip resurfacing arthroplasty: prevalence and metal ion study[J]. J Arthroplasty, 2011, 26(4): 511-518.
[23]
Willert HG, Buchhorn GH, Fayyazi A, et al. Metal-on-metal bearings and hypersensitivity in patients with artificial hip joints. A clinical and histomorphological study[J]. J Bone Joint Surg Am, 2005, 87(1): 28-36.
[24]
Tower SS. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report[J]. J Bone Joint Surg Am, 2010, 92(17): 2847-2851.
[25]
Mao X, Wong AA, Crawford RW. Cobalt toxicity--an emerging clinical problem in patients with metal-on-metal hip prostheses?[J]. Med J Aust, 2011, 194(12): 649-651.
[26]
Smith AJ, Dieppe P, Porter M, et al. Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: link age study between the National Joint Registry of England and Walesand hospital episode statistics[J/OL]. BMJ, 2012, 344(7870):e2383. DOI: 10.1136/bmj.e2383.
[27]
Robinson PG, Wilkinson AJ, Meek RM. Metal ion levels and revision rates inmetal-on-metal hip resurfacing arthroplasty:a comparative study[J]. Hip Int, 2014, 24(2): 123-128.
[28]
Griffin WL, Fehring TK, Kudrna JC, et al. Are metal ion levelsa useful trigger for surgical intervention?[J]. J Arthroplasty, 2012, 27(8): 32-36.
[29]
Malek IA, King A, Sharma H, et al. The sensitivity, specificity and predictive values of raised plasma metal ion levels in the diagnosis of adverse reaction to metal debris in symptomatic patients with a metal-on-metal arthroplasty of the hip[J]. J Bone Joint Surg Br, 2012, 94(8): 1045-1050.
[30]
De Smet K, De Haan R, Calistri A, et al. Metalion measurement as a diagnostic tool to identify problems with metal-on-metal hip resurfacing[J]. J Bone Joint Surg Am, 2008, 90(4): 202-208.
[31]
Amstutz HC, Le DM. Hip resurfacing: history, current status, and future[J]. Hip Int, 2015, 25(4): 330-338.
[32]
Reito A, Puolakka T, Elo P, et al. Outcome of Birmingham hip resurfacing at ten years: role of routine whole blood metal ion measurements inscreening for pseudotumours[J]. Int Orthop, 2014, 38(11): 2251-2257.
[33]
Bauer TW, Campbell PA, Hallerberg G, Biological Working Group. How have new bearing surfaces altered the local biological reactions to by products of wear and modularity?[J]. Clin Orthop Relat Res, 2014, 472(12): 3687-3698.
[1] 丁莹莹, 宋恺, 金姬延, 田华. 机器人辅助膝髋关节置换术后精细化临床护理[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 553-557.
[2] 孔德铭, 刘铮, 李睿, 钱文伟, 王飞, 蔡道章, 柴伟. 人工智能辅助全髋关节置换三维术前规划准确性评价[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 431-438.
[3] 刘琴, 刘瀚旻, 谢亮. 基质金属蛋白酶在儿童哮喘发生机制中作用的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 564-568.
[4] 刘欢, 邢皓, 常正奇, 张记. 机械敏感性离子通道蛋白Piezo1在感染相关疾病中的研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 263-269.
[5] 李星月, 董伟, 徐永波, 张文法, 胡晓璇, 钟玉绪, 褚海波. 浅表血栓性静脉炎管壁基质金属蛋白酶及其抑制剂表达研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 338-343.
[6] 吴春风, 卢国汉, 姚汝贺, 李健辉, 陈文杰, 黄宇. 21 F膀胱镜鞘联合8.0/9.8 F输尿管镜与等离子电切镜在膀胱结石钬激光碎石术中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 579-584.
[7] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[8] 井发红, 李丽娜, 高婷, 高艳梅, 杨楠, 李卓, 慕玉东. 肺癌立体定向放疗血清SAP 和MMPs 表达及临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 707-713.
[9] 梁丽斯, 李洁, 贺帅, 来艳君, 刘铭, 张琳. MMP-9、MMP-2 及TLR4、HE4对非小细胞肺癌早期诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 756-761.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
[12] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[13] 唐玉天, 王艳芝, 王毅, 任益民, 张雁山, 赵文学, 王芳, 杨文源. HFOV 控制胸腹部肿瘤碳离子精准治疗患者呼吸运动的安全性分析[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 344-350.
[14] 钟小军, 杨清峰, 邹忠元, 丘宁宁, 李见英, 邹四珍, 黄小琴, 郭冠华, 牛立志. 支气管镜联合数字减影血管造影在恶性气道狭窄金属支架置入中的应用[J/OL]. 中华介入放射学电子杂志, 2024, 12(04): 317-322.
[15] 刘聪辉, 何浩然, 黄一诺, 张凤, 王凡月, 郝翰. 膳食铜补充对大鼠心肌梗死后心肌基质金属蛋白酶2表达水平及血流动力学的影响[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 166-172.
阅读次数
全文


摘要